封面
市場調查報告書
商品編碼
1611108

美國周邊神經損傷市場規模、佔有率、趨勢分析報告:按產品/療法、按程序、按應用、按最終用途、按地區、按細分市場預測,2025-2030 年

U.S. Peripheral Nerve Injuries Market Size, Share & Trends Analysis Report By Products/Therapies (Nerve Grafting, Biomaterial), By Surgery, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國周邊神經損傷市場的成長和趨勢

根據Grand View Research, Inc.最新報告,預計到2030年,美國周邊神經損傷市場規模將達到7.125億美元,2025年至2030年複合年成長率為7.4%。該市場的成長歸因於美國醫療保健支出的增加、周邊神經損傷盛行率的增加、對研發的日益關注以及患者對微創手術的偏好增加。

技術進步正在徹底改變美國的周邊神經損傷治療領域。神經移植、神經導管和神經刺激設備等新型創新治療方案正在幫助改善治療結果並加速患者復原。此外,微創手術技術的使用,如終末神經縫合和神經減壓手術,由於具有更快恢復的優點而在患者中越來越受歡迎。醫療技術的這些進步透過提供更有效、侵入性更小的治療方法正在推動市場成長。

主要市場參與企業的投資以及學術界、工業界和醫療機構之間的合作正在推動研發工作,從而發現新的治療方法。例如,2022 年 6 月,再生醫學領域領先的生物技術公司 Vascudyne, Inc.津貼,用於一項名為「使用再生工程組織管生產周圍神經包裹」的研究。該研究將從 2022 年 6 月開始資助一年,資助金額為 10 萬美元,並將利用 Bascudine 的 TRUE Tissue 技術。

COVID-19 大流行正在推動對微創手術的需求,因為它具有更快的恢復時間、可能更低的成本、更好的治療選擇以及與遠端醫療技術整合等優點。這些因素可能會對美國周邊神經損傷市場產生正面影響。

美國周邊神經損傷市場報告亮點

  • 從產品/療法來看,由於自體移植、同種異體移植和合成導管等神經移植技術的快速發展,神經移植領域將在 2024 年佔據美國周邊神經損傷市場佔有率65.1% 的佔有率。
  • 透過手術,直接神經修復佔據了美國周邊神經損傷市場的主導地位,佔據了最大的銷售佔有率,約42.5%。它被認為是重症病例手術治療的黃金標準。
  • 從應用來看,2024年上肢部分在美國周邊神經損傷市場佔有率中所佔比重最大,佔81.2%。意外跌倒和Guillain-Barré二氏症候群、糖尿病和腕隧道症候群等疾病的發病率正在上升,預計將推動這一細分市場的發展。
  • 按最終用途分類,醫院細分市場將在 2024 年佔據主導地位。醫院數量的增加和醫院手術病例的增加預計將推動這一領域的發展。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國周邊神經損傷市場變數、趨勢、範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章美國周邊神經損傷市場:產品/療法業務分析

  • 2024 年及 2030 年產品/療法市場佔有率
  • 產品/治療細分儀表板
  • 2018-2030 年按產品/療法分類的市場規模、預測和趨勢分析
  • 神經移植
  • 生物材料

第5章美國周邊神經損傷市場:手術業務分析

  • 2024年及2030年手術市場佔有率
  • 手術細分儀表板
  • 2018-2030 年按手術分類的市場規模、預測與趨勢分析
  • 直接神經修復
  • 神經移植
  • 幹細胞療法
  • 內神經松解術
  • 神經縫合

第6章美國周邊神經損傷市場:應用業務分析

  • 2024年及2030年應用市場佔有率
  • 使用細分儀表板
  • 2018-2030 年市場規模、預測與趨勢分析(按應用)
  • 上肢
  • 下肢

第7章美國周邊神經損傷市場:最終用途業務分析

  • 2024 年及 2030 年最終用途市場佔有率
  • 最終用途細分儀表板
  • 2018-2030 年按最終用途分類的市場規模、預測與趨勢分析
  • 醫院
  • 診所
  • 門診手術中心
  • 其他

第8章 競爭格局

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • Axogen Corporation
    • Stryker
    • Regenity
    • Integra LifeSciences Corporation
    • TOYOBO CO., LTD.
    • Alafair Biosciences, Inc.
    • SYNOVIS MICRO COMPANIES ALLIANCE, INC.,(BAXTER INTERNATIONAL INC.)
Product Code: GVR-4-68040-070-4

U.S. Peripheral Nerve Injuries Market Growth & Trends:

The U.S. peripheral nerve injuries market size is estimated to reach USD 712.5 million by 2030, registering a CAGR of 7.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is due to increasing healthcare expenditure in the U.S., an increasing prevalence of peripheral nerve injuries, growing focus on research and development, and a growing patient preference for minimally invasive procedures.

Technological advancements are revolutionizing the field of peripheral nerve injury treatment in the U.S. New and innovative treatment options such as nerve grafts, nerve conduits, and neurostimulation devices are providing improved outcomes and helping patients recover faster. Additionally, the use of minimally invasive surgical techniques, such as end-to-end nerve sutures and nerve decompression procedures, is gaining popularity among patients due to their benefits of faster recovery times. These advancements in medical technology are driving the growth of the market by providing more effective and less invasive treatment options.

Investments from key market players and collaborations between academia, industry, and healthcare institutions are driving R&D efforts, leading to the discovery of new treatment modalities. For instance, in June 2022, Vascudyne, Inc., a leading biotechnology company in regenerative medicine, was awarded a grant from Regenerative Medicine Minnesota for a research study titled "Production of a Peripheral Nerve Wrap Using Tissue Tubes from Regenerative Engineering." The study will be funded with USD 100,000 for one year, starting in June 2022, and will utilize Vascudyne's TRUE Tissue technology.

The COVID-19 pandemic has boosted the demand for minimally invasive procedures as it offer benefits such as shorter recovery times, potentially lower costs, better treatment options, and integration with telemedicine technologies. These factors may impact the market for U.S. peripheral nerve injuries positively.

U.S. Peripheral Nerve Injuries Market Report Highlights:

  • Based on product/therapies, Nerve grafting segment dominated the U.S. peripheral nerve injury market share in 2024, accounting for 65.1%, owing to rapid advancements in nerve grafting techniques, such as autografts, allografts, and synthetic conduits
  • Based on surgery, direct nerve repair segment dominated the U.S. peripheral nerve injury market and held the largest revenue share of nearly 42.5%. It is considered the gold standard of surgical treatment for severe cases
  • Based on application, upper extremities segment held the largest U.S. peripheral nerve injury market share in 2024, accounting for 81.2%. increasing incidence of accidental falls and medical conditions, such as Guillain-Barre syndrome, diabetes, & carpal tunnel syndrome, is expected to drive the segment
  • Based on end use, hospitals segment dominated the market in 2024. Increasing number of hospitals and surgical cases in hospitals are expected to boost the segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Products/Therapies
    • 1.2.2. Surgery
    • 1.2.3. Application
    • 1.2.4. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Peripheral Nerve Injury Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Peripheral Nerve Injury Market: Products/Therapies Business Analysis

  • 4.1. Products/Therapies Market Share, 2024 & 2030
  • 4.2. Products/Therapies Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Products/Therapies, 2018 to 2030 (USD Million)
  • 4.4. Nerve Grafting
    • 4.4.1. Nerve Grafting Market, 2018 - 2030 (USD Million)
    • 4.4.2. Autograft
      • 4.4.2.1. Autograft Market, 2018 - 2030 (USD Million)
    • 4.4.3. Allograft
      • 4.4.3.1. Allograft Market, 2018 - 2030 (USD Million)
    • 4.4.4. Stem Cell Therapy
      • 4.4.4.1. Stem Cell Therapy Market, 2018 - 2030 (USD Million)
  • 4.5. Biomaterial
    • 4.5.1. Biomaterial Market, 2018 - 2030 (USD Million)
    • 4.5.2. Nerve Conduit
      • 4.5.2.1. Nerve Conduit Market, 2018 - 2030 (USD Million)
    • 4.5.3. Nerve Protector
      • 4.5.3.1. Nerve Protector Market, 2018 - 2030 (USD Million)
    • 4.5.4. Nerve Connector
      • 4.5.4.1. Nerve Connector Market, 2018 - 2030 (USD Million)
    • 4.5.5. Nerve Wraps
      • 4.5.5.1. Nerve Wraps Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Peripheral Nerve Injury Market: Surgery Business Analysis

  • 5.1. Surgery Market Share, 2024 & 2030
  • 5.2. Surgery Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Surgery, 2018 to 2030 (USD Million)
  • 5.4. Direct Nerve Repair
    • 5.4.1. Direct Nerve Repair Market, 2018 - 2030 (USD Million)
  • 5.5. Nerve Grafting
    • 5.5.1. Nerve Grafting Market, 2018 - 2030 (USD Million)
  • 5.6. Stem Cell Therapy
    • 5.6.1. Stem Cell Therapy Market, 2018 - 2030 (USD Million)
  • 5.7. Internal Neurolysis
    • 5.7.1. Internal Neurolysis Market, 2018 - 2030 (USD Million)
  • 5.8. Neurorrhaphy
    • 5.8.1. Neurorrhaphy Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Peripheral Nerve Injury Market: Application Business Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Application Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Upper Extremities
    • 6.4.1. Upper Extremities Market, 2018 - 2030 (USD Million)
  • 6.5. Lower Extremities
    • 6.5.1. Lower Extremities Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Peripheral Nerve Injury Market: End Use Business Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. End Use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 7.5. Clinics
    • 7.5.1. Clinics Market, 2018 - 2030 (USD Million)
  • 7.6. Ambulatory Surgical Centers
    • 7.6.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Axogen Corporation.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Stryker
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Regenity
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Integra LifeSciences Corporation.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. TOYOBO CO., LTD.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Alafair Biosciences, Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC., (BAXTER INTERNATIONAL INC.)
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. peripheral nerve injury market, by product/therapies, 2018 - 2030 (USD Million)
  • Table 4. U.S. peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 5. U.S. peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 6. U.S. peripheral nerve injury market, end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. peripheral nerve injury market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Segment outlook
  • Fig. 9 Competitive landscape
  • Fig. 10 U.S. peripheral nerve injury market dynamics
  • Fig. 11 U.S. peripheral nerve injury market: Porter's five forces analysis
  • Fig. 12 U.S. peripheral nerve injury market: PESTLE analysis
  • Fig. 13 U.S. peripheral nerve injury market: Products/therapies segment dashboard
  • Fig. 14 U.S. peripheral nerve injury market: Products/therapies market share analysis, 2024 & 2030
  • Fig. 15 Nerve grafting market, 2018 - 2030 (USD Million)
  • Fig. 16 Autograft market, 2018 - 2030 (USD Million)
  • Fig. 17 Allograft market, 2018 - 2030 (USD Million)
  • Fig. 18 Stem cell therapy market, 2018 - 2030 (USD Million)
  • Fig. 19 Biomaterial market, 2018 - 2030 (USD Million)
  • Fig. 20 Nerve conduit market, 2018 - 2030 (USD Million)
  • Fig. 21 Nerve protector market, 2018 - 2030 (USD Million)
  • Fig. 22 Nerve connector market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. peripheral nerve injury market: Surgery segment dashboard
  • Fig. 24 U.S. peripheral nerve injury market: Surgery market share analysis, 2024 & 2030
  • Fig. 25 Direct nerve repair market, 2018 - 2030 (USD Million)
  • Fig. 26 Nerve grafting market, 2018 - 2030 (USD Million)
  • Fig. 27 Stem cell therapy market, 2018 - 2030 (USD Million)
  • Fig. 28 Carpal tunnel release market, 2018 - 2030 (USD Million)
  • Fig. 29 Internal neurolysis market, 2018 - 2030 (USD Million)
  • Fig. 30 Neurorrhaphy market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. peripheral nerve injury market: Application segment dashboard
  • Fig. 32 U.S. peripheral nerve injury market: Application market share analysis, 2024 & 2030
  • Fig. 33 Upper extremities market, 2018 - 2030 (USD Million)
  • Fig. 34 Lower extremities market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. peripheral nerve injury market: End use segment dashboard
  • Fig. 36 U.S. peripheral nerve injury market: End use market share analysis, 2024 & 2030
  • Fig. 37 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 38 Clinics market, 2018 - 2030 (USD Million)
  • Fig. 39 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 40 Others market, 2018 - 2030 (USD Million)
  • Fig. 41 Company categorization
  • Fig. 42 Company market position analysis
  • Fig. 43 Strategic framework